Raymond J. Henley Iii

Array ( [id] => 6906213 [patent_doc_number] => 20050101608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Iloprost in combination therapies for the treatment of pulmonary arterial hypertension' [patent_app_type] => utility [patent_app_number] => 10/945255 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4305 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101608.pdf [firstpage_image] =>[orig_patent_app_number] => 10945255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4515451 [patent_doc_number] => 07932241 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Pharmaceutical products comprising bisphosphonates' [patent_app_type] => utility [patent_app_number] => 10/570339 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9707 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932241.pdf [firstpage_image] =>[orig_patent_app_number] => 10570339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207656 [patent_doc_number] => 20050043382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Novel combination of a factor Xa inhibitor and clopidogrel' [patent_app_type] => utility [patent_app_number] => 10/939767 [patent_app_country] => US [patent_app_date] => 2004-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6020 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043382.pdf [firstpage_image] =>[orig_patent_app_number] => 10939767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682955 [patent_doc_number] => 20080249181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Compositions Having Antimycrobial Activity Including a Hydroxamate or a Hydroxamate and a Hydroxlyamine' [patent_app_type] => utility [patent_app_number] => 10/592254 [patent_app_country] => US [patent_app_date] => 2004-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11559 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249181.pdf [firstpage_image] =>[orig_patent_app_number] => 10592254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083876 [patent_doc_number] => 20050049256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Treatment of inflammatory autoimmune diseases with alpha-adrenergic antagonists and beta-adrenergic agonists' [patent_app_type] => utility [patent_app_number] => 10/928437 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10743 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049256.pdf [firstpage_image] =>[orig_patent_app_number] => 10928437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083845 [patent_doc_number] => 20050049225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Use of bisphosphonates for otosclerosis' [patent_app_type] => utility [patent_app_number] => 10/926565 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6846 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049225.pdf [firstpage_image] =>[orig_patent_app_number] => 10926565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7237687 [patent_doc_number] => 20050080023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Osteoclastogenesis inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/925608 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 8746 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080023.pdf [firstpage_image] =>[orig_patent_app_number] => 10925608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534362 [patent_doc_number] => 07888334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Mitoquinone derivatives used as mitochondrially targeted antioxidants' [patent_app_type] => utility [patent_app_number] => 10/568654 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20671 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888334.pdf [firstpage_image] =>[orig_patent_app_number] => 10568654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7238720 [patent_doc_number] => 20050080136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Powder of amino acids and method for producing the same' [patent_app_type] => utility [patent_app_number] => 10/921895 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5523 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080136.pdf [firstpage_image] =>[orig_patent_app_number] => 10921895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206856 [patent_doc_number] => 20050043318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Chemokine inhibiting piperazine derivatives and their use to treat myocarditis' [patent_app_type] => utility [patent_app_number] => 10/923464 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16814 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043318.pdf [firstpage_image] =>[orig_patent_app_number] => 10923464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 505830 [patent_doc_number] => 07202278 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-10 [patent_title] => '4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical' [patent_app_type] => utility [patent_app_number] => 10/920395 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4428 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202278.pdf [firstpage_image] =>[orig_patent_app_number] => 10920395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 463905 [patent_doc_number] => 07238718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Method for treating myolytic disease and method for screening antimyolytic agent' [patent_app_type] => utility [patent_app_number] => 10/919473 [patent_app_country] => US [patent_app_date] => 2004-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 2890 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238718.pdf [firstpage_image] =>[orig_patent_app_number] => 10919473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103491 [patent_doc_number] => 20050106217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Stimulation of CPT-1 as a means to reduce weight' [patent_app_type] => utility [patent_app_number] => 10/917525 [patent_app_country] => US [patent_app_date] => 2004-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5060 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106217.pdf [firstpage_image] =>[orig_patent_app_number] => 10917525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216729 [patent_doc_number] => 20050054663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'GSK-3 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/917707 [patent_app_country] => US [patent_app_date] => 2004-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15640 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054663.pdf [firstpage_image] =>[orig_patent_app_number] => 10917707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 903381 [patent_doc_number] => 07335651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Compositions incorporating(-)-hydroxycitric acid and related methods for promoting fat oxidation' [patent_app_type] => utility [patent_app_number] => 10/911095 [patent_app_country] => US [patent_app_date] => 2004-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5907 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335651.pdf [firstpage_image] =>[orig_patent_app_number] => 10911095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 408244 [patent_doc_number] => 07285562 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-23 [patent_title] => 'Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/900957 [patent_app_country] => US [patent_app_date] => 2004-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9284 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285562.pdf [firstpage_image] =>[orig_patent_app_number] => 10900957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 687011 [patent_doc_number] => 07078437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-18 [patent_title] => 'Apolipoprotein D degradation inhibitor' [patent_app_type] => utility [patent_app_number] => 10/899155 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2052 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078437.pdf [firstpage_image] =>[orig_patent_app_number] => 10899155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089744 [patent_doc_number] => 20050009857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Powder formulations containing tiotropium suitable for inhalation' [patent_app_type] => utility [patent_app_number] => 10/899782 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3936 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009857.pdf [firstpage_image] =>[orig_patent_app_number] => 10899782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051859 [patent_doc_number] => 20070032404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Methods for treating diabetes and related disorders using pde10a inhibitors' [patent_app_type] => utility [patent_app_number] => 10/564680 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8552 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032404.pdf [firstpage_image] =>[orig_patent_app_number] => 10564680 [rel_patent_id] =>[rel_patent_doc_number] =>)